Xebra's Executes First Partnership with the Most Prestigious Agricultural University in Mexico
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2023) - Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAD) (FSE: 9YC0) ("Xebra"), a cannabis company, is pleased to announce it has executed it first joint venture, in the form of research and collaboration partnership with Mexico's most prestigious agricultural university, Chapingo Autonomous University (ChAU), which will focus on the development of innovation and the commercial application of, cannabis with less than 1% THC for in Mexico.
The Chapingo Autonomous University (ChAU), was founded in 1854 as the "National School of Agriculture." In 1974, a bill passed creating the Chapingo Autonomous University, making it the oldest and most important agricultural university in Mexico with a total of 11,200 students, of which 700 are postgraduates and 1,082 are professors. The ChAU covers a broad geographical span of facilities and farms across 12 states of Mexico.
After signing, the first collaborative actions between ChAU and Xebra were agreed to, which include but are not limited to,
1) the import of a wide selection of cannabis seeds,
2) the development of cannabis crops in different regions of Mexico to assess the strains that best suit those regions and that also help to control pests and the resistance to diseases,
3) aid and support in the production of high cannabinoid yielding sativa L cannabis crops with less than 1% THC both in the fields of Xebra Brands and in different farms controlled by the University of Chapingo throughout Mexico.
4) most importantly, the Chapingo University as the agricultural technical expert, has suggested that the COFEPRIS (Mexican FDA) guidelines have to be considered agronomically viable for the historical, first cannabis authorization given to Xebra's subsidiary Desart MX (Xebra Mexico) last week.
Also, Dr. Roberto Rendon Medel, Research Professor and Technical Manager of the Agreement on behalf of Chapingo, emphasizes the potential of the University to research and develop innovations through its students and professors. "As an agricultural and rural university in Mexico, we are convinced that relationships with companies like Xebra enhance the scope of our research and technological developments for the benefit of the Mexican population, economy, and environment."
"The combination of Chapingo University's agricultural expertise and research capabilities, along with Xebra's exclusive cannabis authorizations in Mexico, make this collaboration an important & exciting public-private partnership," says Todd Dalotto, Xebra Brand's Chief Science Officer
Xebra is an international cannabis cultivation and product company, with global brands and intellectual property. Our focus includes beverages, wellness and leisure. Xebra is an absolute first mover in the Mexican cannabis sector with the first ever granted authorization to a corporation by the COFEPRIS. In Canada, Xebra retails its unique Vicious Citrus OG & NEO THC/CBN Lemonades.
For more information contact:
+1 (833) XEBRA 88
Certain information contained in this press release constitutes forward-looking statements under applicable securities laws. Any statements that are not statements of historical fact may be deemed to be forward-looking statements, these include, without limitation, statements regarding Xebra Brands Ltd.'s expectations in respect of its ability to successfully execute its business plan or business model; its ability to enter into and execute partnerships or joint venture opportunities on acceptable terms; its ability to provide economic, environmental, social, or any benefits of any type in the communities it operates in or may operate it in the future; its ability to be a first mover in a country, or to obtain or retain government licenses, permits or authorizations in general, or specifically in Mexico, Canada, or elsewhere, including cannabis authorizations from the Mexican Health Regulatory Agency (COFEPRIS); its ability to satisfy the conditions of authorizations granted by COFEPRIS; its ability to successfully apply for, obtain and retain trademarks and other intellectual property in any jurisdiction; its ability to be cost competitive; its ability to commercialize, cultivate, grow, or process hemp or cannabis in Mexico, Canada, or elsewhere and related plans and timing; its ability to manufacture, commercialize or sell cannabis-infused beverages, wellness products, or other products in Mexico, Canada, or elsewhere, and its related plans and claims, including market interest and availability; its ability to create wellness products that have a therapeutic effect or benefit; plans for future growth and the direction of the business; plans to increase product volumes, the capacity of existing facilities, supplies from third party growers and contractors; expected growth of the cannabis industry generally; management's expectations, beliefs and assumptions in general, including manufacturing costs, production activity and market potential in Mexico or any jurisdiction; events or developments that Xebra expects to take place in the future; general economic conditions; and other risk factors described in the MD&A of the Company for the period ended November 30, 2022. All statements, other than statements of historical facts, are forward-looking information and statements. The words "aim", "believe", "expect", "anticipate", "contemplate", "target", "intends", "continue", "plans", "budget", "estimate", "may", "will", and similar expressions identify forward-looking information and statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by Xebra as of the dates of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements. Such factors include, but are not limited to, the inability of Xebra to retain the authorizations granted by COFEPRIS, the inability to generate sufficient revenues or to raise sufficient funds to carry out its business plan; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete potential acquisitions, dispositions or joint ventures for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; and the timely receipt of regulatory approvals for license applications on terms satisfactory to Xebra. In addition, there is no assurance Xebra will: be a low-cost producer or exporter; obtain a dominant market position in any jurisdiction; have products that will be unique. The foregoing list is not exhaustive and Xebra undertakes no obligation to update or revise any of the foregoing except as required by law. Many of these uncertainties and contingencies could affect Xebra's actual performance and cause its actual performance to differ materially from what has been expressed or implied in any forward-looking statements made by, or on behalf of, Xebra. Readers are cautioned that forward-looking statements are not guarantees of future performance and readers should not place undue reliance on such forward-looking statements. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those set out in such statements.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/158657